Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q3 2024 vs. Q2 2024
How the institutions holding Alterity Therapeutics Ltd changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 10 | 13 | +3 |
| Shares | 78.0K | 112.7K | +34.7K (+44.5%) |
| Value | $140.9K | $148.6K | +$7.70K (+5.5%) |
New holders (4)
Institutions that held Alterity Therapeutics Ltd at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HB Wealth Management, LLC | 23,783 | $31.2K | 0.00% |
| Citadel Advisors LLC | 11,488 | $15.4K | 0.00% |
| Ronald Blue Trust, Inc. | 40 | $72 | 0.00% |
| Danske Bank A/S | 1 | $1 | 0.00% |
Sold out (1)
Institutions that held Alterity Therapeutics Ltd at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| CoreCap Advisors, LLC | 21 | $38 |